[Editor’s Note: The news is starting to come in from DAVOS on the business of cannabis. If you’re an investor, this is of interest.]
The Cannabis Business is Booming — But that’s not Necessarily Good if You’re an Investor
- Everybody wants to be in the cannabis space and I think Investors have to be selective because … there will be a new name every week,” the CEO of a pot growing company said.
- Last week, William Barr, President Trump’s nominee to lead the U.S. Justice Department, said Congress needs to come up with a plan to overcome the discrepancies between state and federal law.
The pot industry faces a “massive inflationary bubble,” and that means investors have to be careful, a cannabis CEO told CNBC at the World Economic Forum in Davos, Switzerland.
“Many, many people are entering the cannabis space, which is terrific, but they actually have to have a purpose — they should be able to generate a business,” said Bruce Linton, chief of Canada-based Canopy Growth.
“Everybody wants to be in the cannabis space, and I think investors have to be selective because … there will be a new name every week,” Linton warned.
The legalization of cannabis for recreational use in Canada last year boosted interest in the industry. Some U.S. states have also approved the use of cannabis. Utah and Missouri approved the use of marijuana for medical purposes in November, while Michigan gave the green light to its recreational use.
Richard Carleton, chief executive officer of Canadian Securities Exchange (CSE), told CNBC it’s only a matter of time until the United States approves cannabis at the federal level.
It is a matter of “two and half or six and half years, it depends on the presidential cycle,” he said.
Last week, William Barr, who is President Donald Trump’s nominee to lead the U.S. Justice Department, said Congress needs to come up with a plan to overcome the discrepancies between state and federal law. Barr said he is personally against pot, but he opposes a reversal by the former attorney general against a policy that eased federal enforcement of marijuana laws.
The uncertainty about where the U.S. will go will bring volatility to cannabis stocks, according to the CEO of the financial services firm Canaccord Genuity.
“The U.S. — who knows what’s going to happen? Tons of good things could happen, tons of bad news could happen. Therefore you will continue to see a lot of volatility,” Daniel Daviau said.
“Here you’re measuring earnings two years out, and you’re putting a relatively large multiple on that. You don’t need much of a change in attitude to shift the stock price, so you will see a lot of volatility,” he added.
‘Great Opportunity’ in the Next Markets
There are upcoming markets for the cannabis industry, including Israel and European countries. According to Daviau from Canaccord Genuity, “Europe is gonna go nice and slow.”
Ultimately, he said, it’s a “great opportunity, but years in the making.”
Linton recalled: “Who’s got federal legalization on the books? Greece, Germany, England, Denmark, Czech Republic — they are all federally regulated for medical access.”
The three interviewees agreed that the future of cannabis will come from the medical side, which will subsequently open the doors to wider recreational uses.
“If we reconvene in five years, the proportion which is smoked will be a very small fraction,” Linton said.
“And that’s because medical” will create better product, he added, citing the hypothetical example of anti-anxiety beverages that could be tested medically and then be sold as a way for people to be socially active with greater ease.
Original Article: Pot business: A cannabis industry bubble creates investing challenges, CNBC
Photo: Tom Franck | CNBC
Canopy Growth operations in Smiths Falls, Ontario.
[Editor’s Note: All-american Joe goes all in on cannabis. This is yet another piece of the normalization of cannabis puzzle.]
Call him Grow Montana … because the NFL Hall of Famer is investing HEAVILY in the weed business.
62-year-old Joe Montana is one of the major investors of a company called Caliva — a major legal marijuana operation out of San Jose, CA. The company not only grows weed — it also sells everything from joints to vape pens and even marijuana beverages.
Montana started a venture fund back in 2015 — and when Caliva was seeking investors for a $75 million round of funding, Montana’s company joined in. Caliva CEO Dennis O’Malley issued a statement saying the company plans on opening retail stores in major cities in 2019.
He added, “What we’re trying to do is be the #1 brand in California … We believe this is where global brands are made.”
As for why Montana decided to invest — O’Malley says Joe believes the company will “make a serious impact on opioids use or addiction.”
Original Article: Joe Montana Invests Heavily In Marijuana Business | TMZ.com
Older dogs have seen their owners through years of stress and hustle. They’ve accommodated and adapted. They’ll accompany you through travels in the cold or rain. Your aging dog will trek through different environments with little resistance. However, to really care for an older dog, and reduce your older dog’s stress, is to take note of their aging bones and aching paws throughout the year.
Life can be filled with shopping, long hours of traveling, little kids running around, and visitors that can bring added stress. While the best thing about pets is that they are the most empathetic towards you, they can feel the stress of your emotions as well.
A recent 2018 pharmacokinetic and clinical study done by the College of Veterinary Medicine at Cornell University has determined that “2 mg/kg of CBD twice daily can help increase comfort and activity in dogs with OA (osteoarthritis).” The study states further that “baseline scores showed a significant decrease in pain and increase in activity (p < 0.01) at week 2 and 4 during CBD treatment.”
Trends in rising CBD usages have increased with new and current state legalizations for production. Companies have accounted for the rise in these trends and have invested in state of the art research to not only gauge the market but to offer the best type of CBD oils – especially those that are natural, organic and best of all, contain no GMOs.
King Kanine, a company that specializes in offering natural CBD oils for ingestion for dogs, offers CBD based topical solutions for dry, aching paws as well as dermal inflammation. Their flagship product line of King Kalm™ CBD is derived from Broad Spectrum Cannabidiol Oils. All their CBD products are compounded by a licensed pharmacist & derived from non-GMO and organic hemp, it is lab tested vigorously and often for its potency and bio-availability. They stand by their trademark of utilizing no flavors, preservatives, or colors whatsoever.
Your dog may no longer be young, but new types of pain or stress relief are always worth the try. Your dog may just love you for trying this!
The Canadian province of Nova Scotia will soon become the only known place in the world with combined liquor-cannabis retailers. The twelve stores are set to open on October 17, the official launch date for Canada’s recreational market.
The retail combination will run through the Nova Scotia Liquor Corporation (NSLC), the province’s government-subsidized alcohol retailer. The NSLC will also be selling cannabis separately through an online e-commerce platform.
The President and CEO of the NSLC Bret Mitchell recently confirmed the news in a press release and guided tour for news outlets. Customers looking to buy cannabis from the NSLC will need to walk through the store’s alcohol retail section to access its cannabis section.
Original Article at Herb.co: Nova Scotia Announces the World’s First Liquor and Cannabis Retail Store
The anti-inflammatory property of delta 3 carene is probably its most impressive characteristic, allows it to treat arthritis, bursitis, and fibromyalgia.
Cannabis consumers and researchers once thought that all of the medical efficacy of cannabis was contained in just a few cannabinoids. Cannabinoids are the medical molecules known to do everything from kill cancer to treat asthma to battle anxiety and depression. However, special chemicals called terpenes have been found to deliver an equal amount of medical efficacy. One such terpene is delta 3 carene.
Read More at the Original Article on Herb.co: Delta 3 Carene: The Anti-inflammatory, Bone Repairing Terpene
Originally published 4/6/17